JP2022524083A5 - - Google Patents
Info
- Publication number
- JP2022524083A5 JP2022524083A5 JP2021553012A JP2021553012A JP2022524083A5 JP 2022524083 A5 JP2022524083 A5 JP 2022524083A5 JP 2021553012 A JP2021553012 A JP 2021553012A JP 2021553012 A JP2021553012 A JP 2021553012A JP 2022524083 A5 JP2022524083 A5 JP 2022524083A5
- Authority
- JP
- Japan
- Prior art keywords
- therapeutically active
- active biological
- individual
- biological agents
- drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024195155A JP2025020335A (ja) | 2019-03-08 | 2024-11-07 | 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法 |
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962815825P | 2019-03-08 | 2019-03-08 | |
| US62/815,825 | 2019-03-08 | ||
| USPCT/US2019/028750 | 2019-04-23 | ||
| PCT/US2019/028750 WO2019209845A1 (en) | 2018-04-23 | 2019-04-23 | Systems and methods for modifying adaptive dosing regimens |
| US16/391,950 US20190326002A1 (en) | 2018-04-23 | 2019-04-23 | Systems and methods for modifying adaptive dosing regimens |
| US16/391,950 | 2019-04-23 | ||
| PCT/US2020/021742 WO2020185699A1 (en) | 2019-03-08 | 2020-03-09 | Systems and methods for drug-agnostic patient-specific dosing regimens |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024195155A Division JP2025020335A (ja) | 2019-03-08 | 2024-11-07 | 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022524083A JP2022524083A (ja) | 2022-04-27 |
| JP2022524083A5 true JP2022524083A5 (cg-RX-API-DMAC7.html) | 2023-03-17 |
| JP7618239B2 JP7618239B2 (ja) | 2025-01-21 |
Family
ID=72426742
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021553012A Active JP7618239B2 (ja) | 2019-03-08 | 2020-03-09 | 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法 |
| JP2024195155A Pending JP2025020335A (ja) | 2019-03-08 | 2024-11-07 | 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024195155A Pending JP2025020335A (ja) | 2019-03-08 | 2024-11-07 | 薬物に依存しない患者固有の投薬レジメンのためのシステムおよび方法 |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP3935639A1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7618239B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR102839034B1 (cg-RX-API-DMAC7.html) |
| AU (2) | AU2020239014A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3132823A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL286145A (cg-RX-API-DMAC7.html) |
| SG (1) | SG11202109704UA (cg-RX-API-DMAC7.html) |
| WO (1) | WO2020185699A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12064664B2 (en) | 2020-11-10 | 2024-08-20 | Willowview Consulting, Llc | Method and system for dynamically transforming user health and exercise-related data into visual, audio, textual, and physical data representations |
| US20220199266A1 (en) * | 2020-12-10 | 2022-06-23 | DataRobot, Inc. | Systems and methods for using machine learning with epidemiological modeling |
| CN113643785B (zh) * | 2021-07-22 | 2023-09-01 | 海南大学 | 基于dikw图谱的疫苗接种浓度确认方法 |
| JP2023127482A (ja) * | 2022-03-01 | 2023-09-13 | 株式会社島津製作所 | 試料分析装置、試料分析方法、医薬分析装置および医薬分析方法 |
| CN114765076A (zh) * | 2022-04-18 | 2022-07-19 | 柳州市妇幼保健院 | 新生儿个体化氟康唑给药量计算方法及给药方案推荐系统 |
| KR102834065B1 (ko) * | 2022-09-22 | 2025-07-16 | 서울대학교산학협력단 | 약동학적 변화량 예측 장치 및 방법 |
| CN116453669B (zh) * | 2023-06-14 | 2023-08-25 | 武汉大学中南医院 | 一种基于大数据的护理预测方法及装置 |
| WO2025006459A1 (en) * | 2023-06-29 | 2025-01-02 | Prxcision, Inc. | Machine learning for real-time decision support |
| CN118016237A (zh) * | 2024-01-22 | 2024-05-10 | 南栖仙策(南京)高新技术有限公司 | 给药剂量确定方法、装置、电子设备及存储介质 |
| CN120448609B (zh) * | 2025-07-11 | 2025-09-16 | 上海斯丹姆医药开发有限责任公司 | 一种流感疫苗临床试验中的数据可视化方法及系统 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040023211A1 (en) * | 2000-09-15 | 2004-02-05 | Kees Groen | System and method for optimizing drug theraphy for the treatment of diseases |
| EP2171630A1 (en) * | 2007-06-27 | 2010-04-07 | F. Hoffmann-Roche AG | System and method for developing patient specific therapies based on modeling of patient physiology |
| US20130191097A1 (en) * | 2010-01-04 | 2013-07-25 | Mayo Foundation For Medical Education And Research | Erythropoietic stimulating agent (esa) dosage determination |
| US20130041683A1 (en) | 2010-04-07 | 2013-02-14 | Novacare | Computer based system for predicting treatment outcomes |
| WO2014055978A1 (en) | 2012-10-05 | 2014-04-10 | Baysient LLC | System and method for providing patient-specific dosing as a function of mathematical models |
| US11501863B2 (en) | 2015-04-09 | 2022-11-15 | Diane R. MOULD | Systems and methods for patient-specific dosing |
| JP2018190244A (ja) * | 2017-05-09 | 2018-11-29 | 塩野義製薬株式会社 | 生理学的モデルによる新規ヒト血漿中濃度推移の予測法 |
-
2020
- 2020-03-09 JP JP2021553012A patent/JP7618239B2/ja active Active
- 2020-03-09 WO PCT/US2020/021742 patent/WO2020185699A1/en not_active Ceased
- 2020-03-09 EP EP20714457.7A patent/EP3935639A1/en active Pending
- 2020-03-09 SG SG11202109704U patent/SG11202109704UA/en unknown
- 2020-03-09 AU AU2020239014A patent/AU2020239014A1/en not_active Abandoned
- 2020-03-09 KR KR1020217032413A patent/KR102839034B1/ko active Active
- 2020-03-09 CA CA3132823A patent/CA3132823A1/en active Pending
-
2021
- 2021-09-05 IL IL286145A patent/IL286145A/en unknown
-
2024
- 2024-11-07 JP JP2024195155A patent/JP2025020335A/ja active Pending
-
2025
- 2025-12-03 AU AU2025275175A patent/AU2025275175A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Andrade-Junior et al. | Skeletal muscle wasting and function impairment in intensive care patients with severe COVID-19 | |
| Garibaldi et al. | Comparison of time to clinical improvement with vs without remdesivir treatment in hospitalized patients with COVID-19 | |
| Najjar et al. | Intravenous erythropoietin in patients with ST-segment elevation myocardial infarction: REVEAL: a randomized controlled trial | |
| Laupacis et al. | The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin | |
| Berendes et al. | Reversible cardiac sympathectomy by high thoracic epidural anesthesia improves regional left ventricular function in patients undergoing coronary artery bypass grafting: a randomized trial | |
| Mulherin et al. | Clinical improvement and radiological deterioration in rheumatoid arthritis: evidence that the pathogenesis of synovial inflammation and articular erosion may differ | |
| Wu et al. | Systematic review of motor function scales and patient-reported outcomes in spinal muscular atrophy | |
| Renaud et al. | Sparing of muscle mass and function by passive loading in an experimental intensive care unit model | |
| JP4560081B2 (ja) | 薬剤の計時投薬の改良された方法 | |
| CN111888463B (zh) | 用于治疗抑郁症的胸腺素β4药物制剂与制备方法及其应用 | |
| Boyle et al. | The role of inflammation in acute psychosocial stress-induced modulation of reward processing in healthy female adults | |
| Magréault et al. | Dosing and route of administration of clindamycin given in combination with rifampicin | |
| US20080249020A1 (en) | Human Growth Hormone Treatment Methods | |
| Sun et al. | Exercise improves pulmonary fibrosis and neurological symptoms via S100A12 inhibition | |
| JP2024527230A5 (cg-RX-API-DMAC7.html) | ||
| Pereiras et al. | Does oral vancomycin prophylaxis for Clostridium difficile infection improve allogeneic hematopoietic stem cell transplant outcomes? | |
| WO2023102970A1 (zh) | 甲状旁腺激素在制备治疗男性抑郁症的药物或保健品中的应用 | |
| RU2449278C1 (ru) | Способ прогноза развития нейтропении, вызванной комбинированной противовирусной терапией, у больных хроническим гепатитом с | |
| Kang et al. | Up-regulation of peroxisome proliferator-activated receptor γ in perennial allergic rhinitis | |
| Otimenyin | Dosage regimen | |
| Li et al. | Safety, pharmacokinetics and population pharmacokinetic model of TQH2722, a novel IL-4Rα monoclonal antibody in healthy subjects: a phase I, first-in-human, single-dose and multiple-dose escalation study | |
| Byrne et al. | Cipaglucosidase alfa plus miglustat in Pompe disease: two non-ambulatory patients switching from high‑dose, high-frequency alglucosidase alfa | |
| Linfield et al. | Impact of Apitegromab on Motor Function in Spinal Muscular Atrophy | |
| Francesco | Evidence-based modalities in the management of Psoriasis and Psoriatic arthritis | |
| Johannsen et al. | O-247 The intrafollicular inflammatory response during ovulation in women is most likely controlled by high concentrations of active cortisol being synthesized shortly before follicular rupture |